Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Cognetivity Neurosciences Ltd (CGNSF) operate in?
Cognetivity Neurosciences Ltd belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Cognetivity Neurosciences Ltd (CGNSF) current stock price?
As of the latest data, Cognetivity Neurosciences Ltd stock price is $0.00, with a previous close of $0.00.
What is Cognetivity Neurosciences Ltd (CGNSF) current market capitalization?
Cognetivity Neurosciences Ltd market cap is approximately 8.96 thousand.
What is Cognetivity Neurosciences Ltd (CGNSF) Earnings Per Share (EPS)?
The trailing EPS is -$0.06.
Does Cognetivity Neurosciences Ltd (CGNSF) pay dividends?
No. Cognetivity Neurosciences Ltd does not pay a dividend.
What is Cognetivity Neurosciences Ltd (CGNSF) beta (volatility) score?
Cognetivity Neurosciences Ltd has a beta of 34.522, indicating very high volatility compared to the market.